HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ribbing disease

A hereditary disorder characterized by progressive thickening and SCLEROSIS of the DIAPHYSES causing pain and swelling of lesions. In contrast to Camurati-Engelmann Syndrome, it is likely autosomal recessive in its inheritance pattern, tends to unilaterally or asymmetrically affect only the limbs, and has a later age of onset. OMIM: 601477
Also Known As:
Diaphyseal sclerosis, multiple; Hereditary multiple diaphyseal sclerosis; Multiple diaphyseal sclerosis
Networked: 5 relevant articles (0 outcomes, 1 trials/studies)

Disease Context: Research Results

Related Diseases

1. Ribbing disease

Experts

1. Cai, Yangting: 1 article (08/2018)
2. Huang, Feng: 1 article (08/2018)
3. Huang, Yaohua: 1 article (08/2018)
4. Lin, Haixiong: 1 article (08/2018)
5. Zhang, Shuncong: 1 article (08/2018)
6. Zheng, Xiaohui: 1 article (08/2018)
7. Carotti, M: 1 article (10/2016)
8. Di Carlo, M: 1 article (10/2016)
9. Salaffi, F: 1 article (10/2016)
10. Silveri, F: 1 article (10/2016)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Ribbing disease:
1. Technetium Tc 99m MedronateIBA
2. Collagen Type II (Type II Collagen)IBA
3. Capsules (Microcapsules)IBA
4. Pamidronate (Aredia)FDA LinkGeneric
5. Celecoxib (Celebrex)FDA Link
6. 6- amino- 1- hydroxyhexane- 1,1- diphosphonateIBA